Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice

Authors: Haidari, Mehran, Wyde, Philip R., Litovsky, Silvio, Vela, Deborah, Ali, Muzammil, Casscells, S. Ward, Madjid, Mohammad

Source: In Atherosclerosis 2010 208(1):90-96

Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans

Authors: Couch, Robert B., Atmar, Robert L., Cate, Thomas R., Quarles, John M., Keitel, Wendy A., Arden, Nancy H., Wells, Janet, Niño, Diane, Wyde, Philip R.

Source: In Vaccine 2009 27(39):5344-5348

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV

Authors: Lokugamage, Kumari G., Yoshikawa-Iwata, Naoko, Ito, Naoto, Watts, Douglas M., Wyde, Philip R., Wang, Nan, Newman, Patrick, Kent Tseng, Chien-Te, Peters, C.J., Makino, Shinji

Source: In Vaccine 2008 26(6):797-808

A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals

Authors: Ojwang, Joshua O., Wang, Yan-Hong, Wyde, Philip R., Fischer, Nikolaus H., Schuehly, Wolfgang, Appleman, James R., Hinds, Soreeta, Shimasaki, Craig D.

Source: In Antiviral Research 2005 68(3):163-172

Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol

Authors: Wyde, Philip R. ^*, Laquerre, Sylvie, Chetty, Srikrishna N., Gilbert, Brian E., Nitz, Theodore J., Pevear, Daniel C.

Source: In Antiviral Research 2005 68(1):18-26

Development of a cotton rat–human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines

Authors: Wyde, Philip R. ^*, Chetty, Srikrishna N., Jewell, Alan M., Schoonover, Shauna L., Piedra, Pedro A.

Source: In Antiviral Research 2005 66(1):57-66

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays

Authors: Wyde, Philip R, Moylett, Edina H, Chetty, Srikrishna N, Jewell, Alan, Bowlin, Terry L, Piedra, Pedro A

Source: In Antiviral Research 2004 63(1):51-59

Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection

Authors: Wyde, Philip R, Chetty, Srikrishna N, Timmerman, Philip, Gilbert, Brian E, Andries, Koen

Source: In Antiviral Research 2003 60(3):221-231

Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus

Authors: Andries, Koen, Moeremans, Marc, Gevers, Tom, Willebrords, Rudy, Sommen, Cois, Lacrampe, Jean, Janssens, Frans, Wyde, Philip R

Source: In Antiviral Research 2003 60(3):209-219

Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro

Authors: Wyde, Philip R., Chetty, Srikrishna N., Jewell, Alan M., Boivin, Guy, Piedra, Pedro A.

Source: In Antiviral Research 2003 60(1):51-59

This result is not displayed to guests.
Login for full access.

Small particle aerosol liposome and liposome-drug combinations for medical use

Modulation of γδ T cells in mouse buccal epithelium following antigen priming

Authors: Otten, Kevin, Wang, Heuy-Ching, Wyde, Philip R, Klein, John R

Source: In Biochemical and Biophysical Research Communications 2002 294(3):626-629

Phase I Study of Adenoviral Delivery of the HSV-tk Gene and Ganciclovir Administration in Patients with Recurrent Malignant Brain Tumors

Authors: Trask, Todd W., Trask, Rebecca P., Aguilar-Cordova, Estuardo, Shine, H.David, Wyde, Philip R., Goodman, J.Clay, Hamilton, Winifred J., Rojas-Martinez, Augusto, Chen, Shu-Hsia, Woo, Savio L.C., Grossman, Robert G.

Source: In Molecular Therapy February 2000 1(2):195-203

Use of cotton rats for preclinical evaluation of measles vaccines

Authors: Wyde, Philip R ^*, Stittelaar, Koert J, Osterhaus, Albert D.M.E, Guzman, Efrain, Gilbert, Brian E

Source: In Vaccine 2000 19(1):42-53

Chemotherapy of respiratory viruses: prospects and challenges

Authors: Wyde, Philip R.

Source: In Drug Resistance Updates August 1999 2(4):244-258

Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo

Authors: Yu, Kuo-Long, Wang, Xiangdong Alan, Civiello, Rita L., Trehan, Ashok K., Pearce, Bradley C., Yin, Zhiwei, Combrink, Keith D., Gulgeze, H. Belgin, Zhang, Yi, Kadow, Kathleen F., Cianci, Christopher W., Clarke, Junius, Genovesi, Eugene V., Medina, Ivette, Lamb, Lucinda, Wyde, Philip R., Krystal, Mark, Meanwell, Nicholas A.

Source: In Bioorganic & Medicinal Chemistry Letters 2006 16(5):1115-1122

Protection against influenza infection by cytokine-enhanced aerosol genetic immunization.

Authors: Orson, Frank M., Kinsey, Berma M., Densmore, Charles L., Nguyen, Tina, Wu, Yan, Mbawuike, Innocent N., Wyde, Philip R.

Source: Journal of Gene Medicine; Apr2006, Vol. 8 Issue 4, p488-497, 10p

Replication of Clinical Measles Virus Strains in Hispid Cotton Rats.

Authors: Wyde, Philip R., Moore-Poveda, Donna K., Daley, Natalie J., Oshitani, Hitoshi

Source: Proceedings of the Society for Experimental Biology & Medicine; May1999, p53-63, 11p

Muramyl Peptides and Polyinosinic—Polycytodylic Acid Given to Mice Prior to Influenza Virus Challenge Reduces Pulmonary Disease and Mortality.

Authors: Wyde, Philip R., Six, Howard R., Ambrose, Mark W., Throop, Bethany J.

Source: Journal of Immunotherapy; Feb1990, Vol. 9 Issue 1, p98-102, 5p